文献速递垂体与肾上腺疾病

库欣综合征患者肠道微生物组特征改变且在缓解后持续存在

Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究前瞻性纳入18例内源性库欣综合征患者(主要为垂体性,n=13),在活动期和术后生化缓解1至2年时采集粪便,并与36例排除库欣综合征的肥胖对照及108例健康瘦学生参考组比较16S rRNA基因V3/V4区测序的微生物谱。结果显示活动期库欣综合征患者肠道微生物谱紊乱,且术后生化缓解后菌群失调仍持续存在。

要点

  • 库欣综合征患者肠道微生物谱与健康瘦参考组相比存在紊乱。
  • 术后生化缓解1至2年后,库欣综合征患者的菌群失调仍持续存在。
  • 该持续紊乱的微生物组可能作为益生菌干预的潜在靶点。

核心结论

  • 库欣综合征患者具有独特且紊乱的肠道微生物组,且这种紊乱在手术后仍持续存在,提示其可能作为额外益生菌干预以加速向健康微生物组趋近的潜在靶点。

研究设计与样本

  • 前瞻性研究,纳入18例不同病因的内源性库欣综合征患者(主要为垂体性库欣综合征,n=13),在活动期及成功手术生化缓解后1至2年提供粪便样本。
  • 另设36例排除库欣综合征的肥胖患者作为对照,并采用108份健康瘦学生样本作为参考组。
  • 对每份样本的16S核糖体RNA基因V3/V4区扩增子进行测序并聚类为操作分类单元,使用R脚本比较库欣综合征患者与对照组及参考组的微生物谱。

主要发现

  • 与健康瘦参考组相比,活动期库欣综合征患者的肠道微生物组呈现紊乱的微生物谱。
  • 库欣综合征患者的微生物失调在根治性手术后生化缓解后仍然维持。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Patients with Cushing's syndrome (CS) suffer from metabolic and cardiovascular comorbidities caused by hypercortisolism. The human gut microbiome responds to different pathological conditions. OBJECTIVE: The aim of our study was to analyze the effect of chronic endogenous cortisol excess on the gut microbiome. METHODS: We prospectively recruited 18 patients with endogenous CS of different etiologies (mainly pituitary CS, n = 13). Patients provided a stool sample during active CS and 1 to 2 years after successful surgical treatment being in biochemical remission. In addition, 36 patients, in whom CS was excluded, served as an obese control group and 108 samples from healthy lean students were used as a reference group. Amplicons of the V3/V4 region of the 16S ribosomal RNA gene, from every sample, were sequenced and clustered into operational taxonomic units. The microbial profiles of CS patients were then compared to the control and reference groups using R scripts. RESULTS: In comparison to lean references, the gut microbiome of patients with florid CS demonstrated a disturbed microbial profile. Microbial dysbiosis of patients with CS was maintained even after biochemical remission following curative surgery. CONCLUSION: Patients with CS have a distinct and disturbed gut microbiome that persists even after surgery, indicating a possible target for additional probiotic interventions to accelerate convergence to a healthy microbiome.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rubinstein G, Lagkouvardos I, Intze E, et al. Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission. J Clin Endocrinol Metab. 2025. PMID: 39715347. doi:10.1210/clinem/dgae887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。